Lubazodone hydrochloride

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameLubazodone hydrochloride
Drug Alias NameSM-50CYM-992YM-35992
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin reuptake inhibitorsSerotonin 2a (5-HT2a) receptor antagonists
TargetsSerotonin 2a (5-HT2a) receptorSerotonin transporter
Therapy Area/IndicationsDepressive Disorder, Major
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAstellas Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstellas Pharma Inc
Active IndicationsN/A
Inactive IndicationsDepressive Disorder, Major

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG